First, the results might support studies indicating that IDH mutation occurs early in a stem/progenitor cell type with subsequent p53 mutations or 1p/19 codeletion defining the path to astrocytoma or oligodendroglioma. The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).